Speaker: Jillian Pintye, RN, MPH, PhD

Title: Extent of in-utero transfer of tenofovir from mother to fetus

Dr. Jillian Pintye, RN, MPH, PhD is an Assistant Professor and nurse-scientist whose research focuses on HIV and STI prevention and treatment, particularly within maternal and child health settings. Dr. Pintye is engaged in a suite of studies related to pre-exposure prophylaxis (PrEP) for HIV prevention among young women in Kenya, including both clinical epidemiology and implementation science studies. Dr. Pintye is currently the Principal Investigator of an NIH R01 grant that will systematically quantify infant pre- and postnatal PrEP exposure and assess birth, bone, growth, and neurocognitive outcomes following PrEP exposure into early childhood. Dr. Pintye is the co-Principal Investigator of an NIH R21 grant which aims to evaluate in utero transfer of antiretroviral drugs used by mothers living with HIV during pregnancy. She is also a co-investigator on multiple implementation science evaluations of point-of-care STI diagnostics, training PrEP providers, and approaches to enhance the reach and quality of PrEP delivery for young women. Prior to graduate school, Dr. Pintye was a Peace Corps Volunteer in Botswana, where she developed a passion for HIV prevention among women and children.